LEADER 04016nam  2200649Ia 450 
001 9910959952903321
005 20251017110109.0
010   $a9780309171946
010   $a0309171946
010   $a9780309501330
010   $a0309501334
035   $a(CKB)110986584753068
035   $a(EBL)3375491
035   $a(SSID)ssj0000279094
035   $a(PQKBManifestationID)11210759
035   $a(PQKBTitleCode)TC0000279094
035   $a(PQKBWorkID)10258239
035   $a(PQKB)10482965
035   $a(MiAaPQ)EBC3375491
035   $a(Au-PeEL)EBL3375491
035   $a(CaPaEBR)ebr10038769
035   $a(OCoLC)923256771
035   $a(Perlego)4734078
035   $a(DNLM)1646125
035   $a(BIP)53855789
035   $a(BIP)6757634
035   $a(EXLCZ)99110986584753068
100   $a20000627d2000      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aEnding neglect $ethe elimination of tuberculosis in the United States /$fLawrence Geiter, editor ; Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention, Institute of Medicine
205   $a1st ed.
210   $aWashington, D.C. $cNational Academy Press$dc2000
215   $a1 online resource (292 p.)
300   $aDescription based upon print version of record.
311 08$a9780309070287 
311 08$a0309070287 
320   $aIncludes bibliographical references and index.
327   $a""Cover""; ""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""1 Fundamentals of Tuberculosis and Tuberculosis Control""; ""2 The Current Situation and How We Got Here""; ""3 Tuberculosis Elimination and the Changing Role of Tuberculosis Control Programs""; ""4 Advancing Toward Elimination""; ""5 Developing the Tools for Tuberculosis Elimination""; ""6 The U.S. Role in Global Tuberculosis Control""; ""7 Mobilizing for Elimination""; ""APPENDIXES""; ""APPENDIX A Statement of Task""; ""APPENDIX B Public Session Agendas""
327   $a""APPENDIX C Site Visit Summaries""""APPENDIX D Role of Public Health Laboratories in the Control of Tuberculosis""; ""APPENDIX E Estimating the Number of Tuberculosis Cases That Can Be Prevented by a Program of Screening and Preventive Therapy of Newly Arrived Immigrants to the United States from Countries with a High Rate of Tuberculosis and the Costs of the Program""; ""APPENDIX F Approval Dates for Existing and Prospects for Development of New Antituberculosis Drugs and Vaccines""; ""APPENDIX G Committee Biographies""; ""Index""
330   $aTuberculosis emerged as an epidemic in the 1600s, began to decline as sanitation improved in the 19th century, and retreated further when effective therapy was developed in the 1950s. TB was virtually forgotten until a recent resurgence in the U.S. and around the world-ominously, in forms resistant to commonly used medicines. What must the nation do to eliminate TB? The distinguished committee from the Institute of Medicine offers recommendations in the key areas of epidemiology and prevention, diagnosis and treatment, funding and organization of public initiatives, and the U.S. role worldwide. The panel also focuses on how to mobilize policy makers and the public to effective action. The book provides important background on the pathology of tuberculosis, its history and status in the U.S., and the public and private response. The committee explains how the U.S. can act with both self-interest and humanitarianism in addressing the worldwide incidence of TB.
606   $aTuberculosis$zUnited States
606   $aInternal medicine
615  0$aTuberculosis
615  0$aInternal medicine.
676   $a614.5/42/0973
701   $aGeiter$b Lawrence$01809245
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910959952903321
996   $aEnding neglect$94359935
997   $aUNINA